Live Breaking News & Updates on Superkine Immunotherapies

Stay updated with breaking news from Superkine immunotherapies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Medicenna Therapeutics (MDNA) Completes MDNA11 Dose Escalation and Commences Monotherapy Dose Expansion in the Phase 1/2 ABILITY Study

Medicenna Therapeutics (MDNA) Completes MDNA11 Dose Escalation and Commences Monotherapy Dose Expansion in the Phase 1/2 ABILITY Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Elizabeth Williams , Delphine Davan , Superkine Immunotherapies , Merck Sharp Dohme , Medicenna Therapeutics Corp , Corporate Communications , Merck Co Inc , Fahar Merchant , Recommended Dose , Clinical Advisory Board , Merck Sharp , Orphan Drug , Looking Statementsthis , Annual Information Form , Annual Report , Chief Financial Officer , Vice President , Investor Relations , Managing Director , Lifesci Advisors , Medicenna Therapeutics ,

Medicenna Therapeutics to Provide Clinical Update from Phase 1/2 ABILITY Study on August 9, 2023

TORONTO and HOUSTON, Aug. 04, 2023 (GLOBE NEWSWIRE) Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a clinical-stage… ....

New York , United States , Kevin Carmichael , Gabriel Friedman , Superkine Immunotherapies , Jake Edmiston , Medicenna Therapeutics Corp , National Post , Medicenna Therapeutics , Provide Clinical Update , Victoria Wells , Financial Times , Financial Post , New York Times , Orphan Drug ,

Medicenna Therapeutics (MDNA) Granted US Patent for the Use of Interleukin-2 Superkine Fusion Proteins in Oncology

Medicenna Therapeutics (MDNA) Granted US Patent for the Use of Interleukin-2 Superkine Fusion Proteins in Oncology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Superkine Immunotherapies , Elizabeth Williams , Tony Russo , Medicenna Therapeutics Corp , Company Superkine , Medicenna Therapeutics , Uses Thereof , Bifunctional Superkine , Fahar Merchant , Orphan Drug , Looking Statementsthis , Annual Information Form , Annual Report , Chief Financial Officer , Russo Partners ,

Medicenna Strengthens IP Portfolio with U.S. Patent Granted for the Use of Interleukin-2 Superkine Fusion Proteins in Oncology

Medicenna Strengthens IP Portfolio with U.S. Patent Granted for the Use of Interleukin-2 Superkine Fusion Proteins in Oncology
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Superkine Immunotherapies , Tony Russo , Elizabeth Williams , Medicenna Therapeutics Corp , Company Superkine , Fusion Proteins , Uses Thereof , Bifunctional Superkine , Fahar Merchant , Orphan Drug , Annual Information Form , Annual Report , Chief Financial Officer , Media Contact , Russo Partners ,

Medicenna Reports First Quarter Fiscal 2024 Financial Results and Operational Highlights

Medicenna Reports First Quarter Fiscal 2024 Financial Results and Operational Highlights
financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.

United States , New York , Kevin Carmichael , Jake Edmiston , Gabriel Friedman , Superkine Immunotherapies , National Post , National Brain Tumor Society , Postmedia Network Inc , Safety Review Committee , Medicenna Therapeutics Corp , Research Roundtable , Medicenna Reports First Quarter Fiscal , Operational Highlights , Review Committee , Victoria Wells , Financial Times , Financial Post , New York Times , Medicenna Therapeutics , Recommended Dose , Fahar Merchant , Minimum Bid , Extension Notice , Common Shares , Postmedia Network ,